Overview

Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone Alone

Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will evaluate the long-term safety and efficacy of dutogliptin in patients with type 2 diabetes mellitus (T2DM).
Phase:
Phase 3
Details
Lead Sponsor:
Forest Laboratories
Collaborator:
Phenomix
Treatments:
Glimepiride
Metformin
Pioglitazone
Sitagliptin Phosphate